ImmunityBio
IBRX
IBRX
49 hedge funds and large institutions have $17.6M invested in ImmunityBio in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 12 closing their positions.
Holders
49
Holders Change
+2
Holders Change %
+4.26%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
13
Reduced
18
Closed
12
Calls
$316K
Puts
$351K
Net Calls
-$35K
Net Calls Change
+$180K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$4.01M |
2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.04M |
3 |
3
Goldman Sachs
New York
|
$232K |
4 |
4
Morgan Stanley
New York
|
$189K |
5 |
5
Renaissance Technologies
New York
|
$4.87M |